0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
The Cutting Edge |

Use of an 800-nm Pulsed-Diode Laser in the Treatment of Recalcitrant Dissecting Cellulitis of the Scalp FREE

Alan S. Boyd, MD; John Q. Binhlam, MD
[+] Author Affiliations

Section Editor: George J. Hruza, MD
Assistant Section Editor: Dee Anna Glaser, MD
Assistant Section Editor: Elaine Siegfried, MD

More Author Information
Arch Dermatol. 2002;138(10):1291-1293. doi:10.1001/archderm.138.10.1291.
Text Size: A A A
Published online

A 35-year-old black man with adult-onset diabetes mellitus presented to our clinics in July 1999 with a 2-year history of alopecia and a boggy scalp with cysts and pustules. He had been previously treated with 40 mg daily of isotretinoin for 3 months (Accutane; Roche Laboratories Inc, Nutley, NJ) and 25 mg daily of dapsone for 2 months with minimal improvement. Oral antibiotic administration was ineffective. The patient complained that in addition to being unsightly, his condition was continuously uncomfortable.

Physical examination of his scalp demonstrated patchy cicatricial alopecia on the crown, vertex, and occiput with variable dyschromia (Figure 1). Numerous pustules, cysts, and erosions were noted.

Place holder to copy figure label and caption
Figure 1.

Diffuse scarring of the scalp from dissecting cellulitis prior to laser-assisted epilation.

Graphic Jump Location

A punch biopsy specimen was taken, which demonstrated a diminished number of follicles with scarring, follicle rupture (Figure 2), and aggregates of neutrophils (Figure 3). These features are compatible with dissecting cellulitis of the scalp.

Place holder to copy figure label and caption
Figure 2.

Scarring alopecia with follicle destruction (hematoxylin-eosin, original magnification ×40).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.

High-power view of the affected dermis with aggregates of neutrophils (hematoxylin-eosin, original magnification ×400).

Graphic Jump Location

The patient was treated with 100 mg of isotretinoin per day for 5 months, which resulted in diminution of the condition but not complete remission. Three months later, the condition flared, and he was treated again with isotretinoin for an additional 2 months with little improvement. Colchicine treatment, 0.6 g twice daily, was begun but discontinued after 2 months because of gastrointestinal adverse effects. Modest improvement was noted. After the treatment with medications was discontinued, however, the cysts and erosions returned. Over the ensuing 6 months, the patient's condition worsened and was associated with increasing discomfort. He was treated with azathioprine, methotrexate, dapsone, ketoconazole, cephalexin, and clarithromycin for the cutaneous disease and celecoxib and gabapentin for the associated pain.

The patient was offered x-ray epilation, but he declined, citing concern over long-term cutaneous malignancy risk. Because the inflammatory response centered around the patient's pilosebaceous units, removal of the offending adnexal structures was undertaken.

Test areas on affected scalp follicles and unaffected follicles from the right mandible were selected and treated using an 800-nm diode laser (Coherent, Santa Clara, Calif) with an actively cooled sapphire tip. Fluences of 10, 15, 20, 23, 26, and 29 J/cm2 were tested at separate sites using a spot size of 9 × 9 mm and pulse duration of 30 milliseconds. At 2 weeks after treatment, there was no evidence of textural or color changes, and the fluence of 29 J/cm2 was selected for use over the entire scalp. The patient's scalp was shaved and treated using a 10% overlapping pattern. Ice packs were applied as needed in the first 24 hours after treatment for pain and swelling. Antibiotic ointment was applied to any areas of crusting, and prednicarbate ointment (Dermatop; Ortho Dermatological, Raratin, NJ) was used for persistent discomfort. Treatment with all systemic medications was discontinued 6 weeks prior to laser treatment. The patient underwent 4 treatment sessions 4 weeks apart to allow sufficient time to evaluate regrowth of treated follicles.

Significant epilation was noted along with a dramatic decrease in the patient's discomfort from the disease (Figure 4). At 6-month follow-up, his condition was quiescent and hair regrowth was not detected.

Place holder to copy figure label and caption
Figure 4.

One month following the final pulsed-diode laser treatment, the patient's scalp is largely free of terminal hairs and inflammation.

Graphic Jump Location

Dissecting cellulitis of the scalp, also known as perifolliculitis abscedens et suffodiens or Hoffman disease, typically affects young black men, although the condition has been described in whites.13 In association with acne conglobata and hidradenitis suppurativa, it is one condition of the so-called follicular occlusion triad, or when considered with pilonidal sinus, the follicular occlusion tetrad. Follicular retention of keratogenous materials suggests a basic pathologic mechanism for these conditions.4 An immunologic attack on displaced follicular or pilar antigens in the deep dermis may be operative.5 Patients initially present with firm to fluctuant nodules on the crown and occiput, which subsequently form sinus tracts that communicate with the skin surface. Secondary infection is common, as is considerable discomfort and embarrassment. Hair follicles are destroyed with ensuing permanent, scarring alopecia. In long-standing cases, squamous cell carcinoma has been reported.6

Determining the best therapy for this condition is frustrating. Systemic antibiotics, x-ray epilation, systemic steroids, zinc sulfate, periodic drainage of fluctuant swellings, and excision with grafting have all been used.2 Curettage of marsupialized cyst walls and ablation using a carbon dioxide laser with healing by secondary intent has also been described.1,2 Recently, isotretinoin has emerged as the medical treatment of choice.2 The drug should be given at 1 mg/kg per day for at least 4 months after the disease is clinically inactive.

The theory underlying laser-assisted hair removal hinges on selective photothermolysis of the targeted follicles by selecting a wavelength that is well absorbed by melanin (400 to 1000 nm) but poorly absorbed by other naturally occurring chromophores such as hemoglobin and water.7 Longer wavelengths improve penetration into the skin, with the most penetrating wavelengths in the range of 600 to 1200 nm.8 Using a wavelength of 700 nm results in significant absorbtion by basal-layer melanin and inadvertent cutaneous damage during hair removal. The duration of the laser pulse must be less than or equal to the thermal relaxation time of the target.9 This allows the follicle to be heated without affecting surrounding tissues.7 The thermal relaxation time of the human hair follicle is estimated to be between 40 and 100 milliseconds. Epidermal melanin disruption is ameliorated by selecting pulse durations longer than the thermal relaxation time of the epidermis, estimated to be 3 to 10 milliseconds. Damage to the superficial skin may also be limited by cooling the surface during treatment. Absorption by underlying oxyhemoglobin within cutaneous blood vessels is minimized by exerting pressure on the laser tip while it is in contact with the skin.10 Several laser epilation systems have been developed, including the ruby laser (694 nm), pulsed-diode laser (800 nm), Nd:YAG laser (1064 nm), alexandrite laser (755 nm), and intense pulsed light source (590-1200 nm).8

The largest study to date using the pulsed-diode laser for hair removal involved the treatment of 38 men and women at varying sites and with variable Fitzpatrick skin types (including types V and VI).10 The pulse width was restricted to half the fluence in joules per square centimeter. The mean treatment fluence was 33.4 J/cm2 using a pulse duration of 5 to 20 milliseconds. Patients were given up to 4 treatments. Fifty-nine percent reported "sparse" regrowth at a mean follow-up time of 8.7 months. Those treated with fluences higher than 30 J/cm2 experienced greater hair loss than those treated with fluences lower than 30 J/cm2. Multiple treatments produced an additive effect. There were no reported cases of infection, textural changes, dyschromia, or scarring. Hair that regrew tended to be thinner and lighter in color.

Use of this laser in patients with follicle-associated disease has been described in 10 women with pseudofolliculitis barbae of the face, neck, groin, and axilla.7 An 810-nm pulsed-diode laser was used with a 9-mm spot size. Pulse duration was held constant at 20 milliseconds with fluences ranging from 30 to 38 J/cm2. Three treatment sessions were administered 6 to 8 weeks apart. All patients reported more than a 50% decrease in hair density and more than a 75% reduction in papule and pustule formation at 2 months after their final treatment. Two patients with associated hyperpigmentation and fibrotic papules also experienced global improvement.

Dissecting cellulitis of the scalp is often a frustrating and recalcitrant disease. In patients not responding to more conservative therapies, laser-assisted epilation should be considered.

Accepted for publication September 18, 2001.

Corresponding author: Alan S. Boyd, MD, 3900 The Vanderbilt Clinic, Nashville, TN 37232 (e-mail: eyebacon@aol.com).

Glass  LFBerman  BLaub  D Treatment of perifolliculitis capitis abscedens et suffodiens with the carbon dioxide laser. J Dermatol Surg Oncol. 1989;15673- 676
Link to Article
Scerri  LWilliams  HCAllen  BR Dissecting cellulitis of the scalp: response to isotretinoin. Br J Dermatol. 1996;1341105- 1108
Link to Article
Stites  CBoyd  AS Dissecting cellulitis in a white male: a case report and review of the literature. Cutis. 2001;6737- 40
Chicarilli  ZN Follicular occlusion triad: hidradenitis suppurativa, acne conglobata and dissecting cellulitis of the scalp. Ann Plast Surg. 1987;18230- 237
Link to Article
Williams  CNCohen  MRonan  SGLewandowski  CA Dissecting cellulitis of the scalp. Plast Reconstr Surg. 1986;77378- 383
Link to Article
Curry  SSGaither  DHKing  LE Squamous cell carcinoma arising in dissecting perifolliculitis of the scalp. J Am Acad Dermatol. 1981;4673- 678
Link to Article
Kauvar  ANB Treatment of pseudofolliculitis with a pulsed infrared laser. Arch Dermatol. 2000;1361343- 1346
Liew  SH Unwanted body hair and its removal: a review. Dermatol Surg. 1999;25431- 439
Link to Article
Anderson  RRParrish  JA Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220524- 527
Link to Article
Campos  VBDierickx  CCFarinelli  WATai-Yuan  DLManuskiatti  WAnderson  RR Hair removal with an 800-nm pulsed diode laser. J Am Acad Dermatol. 2000;43442- 447
Link to Article

Figures

Place holder to copy figure label and caption
Figure 1.

Diffuse scarring of the scalp from dissecting cellulitis prior to laser-assisted epilation.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Scarring alopecia with follicle destruction (hematoxylin-eosin, original magnification ×40).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 3.

High-power view of the affected dermis with aggregates of neutrophils (hematoxylin-eosin, original magnification ×400).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 4.

One month following the final pulsed-diode laser treatment, the patient's scalp is largely free of terminal hairs and inflammation.

Graphic Jump Location

Tables

References

Glass  LFBerman  BLaub  D Treatment of perifolliculitis capitis abscedens et suffodiens with the carbon dioxide laser. J Dermatol Surg Oncol. 1989;15673- 676
Link to Article
Scerri  LWilliams  HCAllen  BR Dissecting cellulitis of the scalp: response to isotretinoin. Br J Dermatol. 1996;1341105- 1108
Link to Article
Stites  CBoyd  AS Dissecting cellulitis in a white male: a case report and review of the literature. Cutis. 2001;6737- 40
Chicarilli  ZN Follicular occlusion triad: hidradenitis suppurativa, acne conglobata and dissecting cellulitis of the scalp. Ann Plast Surg. 1987;18230- 237
Link to Article
Williams  CNCohen  MRonan  SGLewandowski  CA Dissecting cellulitis of the scalp. Plast Reconstr Surg. 1986;77378- 383
Link to Article
Curry  SSGaither  DHKing  LE Squamous cell carcinoma arising in dissecting perifolliculitis of the scalp. J Am Acad Dermatol. 1981;4673- 678
Link to Article
Kauvar  ANB Treatment of pseudofolliculitis with a pulsed infrared laser. Arch Dermatol. 2000;1361343- 1346
Liew  SH Unwanted body hair and its removal: a review. Dermatol Surg. 1999;25431- 439
Link to Article
Anderson  RRParrish  JA Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220524- 527
Link to Article
Campos  VBDierickx  CCFarinelli  WATai-Yuan  DLManuskiatti  WAnderson  RR Hair removal with an 800-nm pulsed diode laser. J Am Acad Dermatol. 2000;43442- 447
Link to Article

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 14

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections